These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 39129926)

  • 1. Fecal Leukocyte Esterase, an Alternative Biomarker to Fecal Calprotectin in Inflammatory Bowel Disease: A Pilot Series.
    Trasolini R; Zhu K; Klemm N; Park S; Salh B
    Gastro Hep Adv; 2022; 1(1):45-51. PubMed ID: 39129926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A simplified fecal leukocyte esterase strip test results as a low cost, widely available, alternative bowel inflammation biomarker.
    Tsai FP; Weng MT; Chang CH; Zeng MH; Wei SC
    J Formos Med Assoc; 2024 Oct; 123(10):1099-1103. PubMed ID: 38331636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness and cost-effectiveness of measuring fecal calprotectin in diagnosis of inflammatory bowel disease in adults and children.
    Yang Z; Clark N; Park KT
    Clin Gastroenterol Hepatol; 2014 Feb; 12(2):253-62.e2. PubMed ID: 23883663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid fecal calprotectin testing to assess for endoscopic disease activity in inflammatory bowel disease: A diagnostic cohort study.
    Kwapisz L; Mosli M; Chande N; Yan B; Beaton M; Micsko J; Mennill PW; Barnett W; Bax K; Ponich T; Howard J; Tirolese A; Lannigan R; Gregor J
    Saudi J Gastroenterol; 2015; 21(6):360-6. PubMed ID: 26655130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Performance of a Novel LIAISON Fecal Calprotectin Assay for Differentiation of Inflammatory Bowel Disease From Irritable Bowel Syndrome.
    Campbell JP; Zierold C; Rode AM; Blocki FA; Vaughn BP
    J Clin Gastroenterol; 2021 Mar; 55(3):239-243. PubMed ID: 32324678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic Accuracy of Fecal Calprotectin for Predicting Relapse in Inflammatory Bowel Disease: A Meta-Analysis.
    Shi JT; Chen N; Xu J; Goyal H; Wu ZQ; Zhang JX; Xu HG
    J Clin Med; 2023 Feb; 12(3):. PubMed ID: 36769850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-life utility and diagnostic accuracy of a home-performed fecal calprotectin test to predict endoscopic activity in patients with inflammatory bowel disease under maintenance treatment with adalimumab.
    Orfanoudaki E; Drygiannakis I; Theodoraki E; Foteinogiannopoulou K; Mantaka A; Koutroubakis IE
    Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e777-e782. PubMed ID: 34284415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Symptoms Do Not Correlate With Findings From Colonoscopy in Children With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis.
    Ricciuto A; Fish J; Carman N; Walters TD; Church PC; Hansen BE; Crowley E; Siddiqui I; Nguyen GC; Kamath BM; Griffiths AM
    Clin Gastroenterol Hepatol; 2018 Jul; 16(7):1098-1105.e1. PubMed ID: 29378308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid fecal calprotectin level assessment and the SIBDQ score can accurately detect active mucosal inflammation in IBD patients in clinical remission: a prospective study.
    Voiosu T; Benguş A; Dinu R; Voiosu AM; Bălănescu P; Băicuş C; Diculescu M; Voiosu R; Mateescu B
    J Gastrointestin Liver Dis; 2014 Sep; 23(3):273-8. PubMed ID: 25267955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic Performance of a Fecal Calprotectin Assay as a Biomarker for Mayo Endoscopic Subscore in Ulcerative Colitis: Result From a Tertiary Referral Center.
    Suttichaimongkol T; Coelho-Prabhu N; Bruining DH; Tariq R; Snyder MR; Loftus EV
    Inflamm Bowel Dis; 2024 Dec; 30(12):2347-2355. PubMed ID: 38309716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal Range of Fecal Calprotectin for Predicting Mucosal Healing in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
    Xiang BJ; Jiang M; Sun MJ; Dai C
    Visc Med; 2021 Oct; 37(5):338-348. PubMed ID: 34722717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The usefulness of fecal calprotectin in assessing inflammatory bowel disease activity.
    Lee YW; Lee KM; Lee JM; Chung YY; Kim DB; Kim YJ; Chung WC; Paik CN
    Korean J Intern Med; 2019 Jan; 34(1):72-80. PubMed ID: 29347813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of diagnostic performance between two quantitative rapid fecal calprotectin assays in detecting active inflammatory bowel disease.
    Lee JM; Jang JH; Ryu JH; Yoo J; Lee BI; Kim SJ; Oh EJ
    PLoS One; 2021; 16(8):e0255974. PubMed ID: 34383847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fecal calprotectin measurement is a marker of short-term clinical outcome and presence of mucosal healing in patients with inflammatory bowel disease.
    Kostas A; Siakavellas SI; Kosmidis C; Takou A; Nikou J; Maropoulos G; Vlachogiannakos J; Papatheodoridis GV; Papaconstantinou I; Bamias G
    World J Gastroenterol; 2017 Nov; 23(41):7387-7396. PubMed ID: 29151692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing Histological Inflammatory Activity in Patients With Ulcerative Colitis: A Diagnostic Accuracy Study Testing Fecal Biomarkers Lactoferrin and Calprotectin.
    Langhorst J; Kairey L; Oberle A; Boone J; Dobos G; Juette H; Tannapfel A; Rueffer A
    Crohns Colitis 360; 2020 Jul; 2(3):otaa053. PubMed ID: 36776494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The diagnostic accuracy of fecal calprotectin during the investigation of suspected pediatric inflammatory bowel disease.
    Henderson P; Casey A; Lawrence SJ; Kennedy NA; Kingstone K; Rogers P; Gillett PM; Wilson DC
    Am J Gastroenterol; 2012 Jun; 107(6):941-9. PubMed ID: 22370604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Automated Fecal Biomarker Profiling - a Convenient Procedure to Support Diagnosis for Patients with Inflammatory Bowel Diseases.
    Kraemer A; Bulgakova T; Schukina O; Kharitidis A; Kharitonov A; Korostovtseva E; Hammar F; Bang H; Lapin S
    Clin Lab; 2020 Jul; 66(7):. PubMed ID: 32658433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Fecal Calprotectin With Endoscopic and Histologic Activity in Pediatric Inflammatory Bowel Disease.
    Crawford E; Gestrich C; Malay S; Young D; Perry S; Splawski J; Sferra TJ; Saab S; Moses J
    JPGN Rep; 2021 Nov; 2(4):e129. PubMed ID: 37206450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fecal calprotectin and its correlation with inflammatory markers and endoscopy in patients from India with inflammatory bowel disease.
    Samant H; Desai D; Abraham P; Joshi A; Gupta T; Dherai A; Ashavaid T
    Indian J Gastroenterol; 2015 Nov; 34(6):431-5. PubMed ID: 26589229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fecal hemoglobin and calprotectin are equally effective in identifying patients with inflammatory bowel disease with active endoscopic inflammation.
    Mooiweer E; Fidder HH; Siersema PD; Laheij RJ; Oldenburg B
    Inflamm Bowel Dis; 2014 Feb; 20(2):307-14. PubMed ID: 24374878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.